Editas Medicine Earning Date (EDIT)

USA |NASDAQ |USD

EDIT Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 23, 2022 Dec 2021 $-0.77 $-0.57 $-1.00
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 23, 2022 Dec 2021 $4.23M - $11.42M

Editas Medicine's next earnings date is Wednesday, Feb 23, 2022 for the fiscal quarter ending Dec 2021.

EDIT Earnings Date & History Chart

EDIT Earnings & Revenue Forecast

EDIT Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 14 $-0.77 $-1.00 $-0.58
Mar 2022 6 $-0.79 $-0.88 $-0.64
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 15 $-3.19 $-4.14 $-2.82
Dec 2022 14 $-3.37 $-4.07 $-2.81

EDIT Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 8 / 0 $-0.86 $-0.87 $-0.92
Mar 2022 3 / 0 $-0.84 $-0.83 $-0.93
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 8 / 0 $-3.40 $-3.47 $-3.58
Dec 2022 5 / 2 $-3.46 $-3.48 $-3.74

EDIT Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 13 $4.23M $-700.00K $8.00M
Mar 2022 7 $3.57M $0.00 $12.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 17 $17.51M $5.40M $30.00M
Dec 2022 15 $25.15M $0.00 $77.50M

EDIT Earnings Date & Revenue History

EDIT Earnings History

|
Show More
Show More

EDIT Revenue History

|
Show More
Show More

Editas Medicine Next Earnings Date & Report

EDIT Next Earnings Date & Report Preview: Dec 2021 (FQ)

EDIT's next earnings date is Wednesday, Feb 23, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 14 analysts, the average EPS estimation for Editas Medicine's next quarterly earnings is $-0.77, with a low EPS estimation of $-1.00, and a high estimation of $-0.58.

Over the last 1 month, EPS estimates have seen 8 upward revisions and 0 downward. The EPS 1 month trend is $-0.86, the last 2 month trend is $-0.87, and the 3 month trend is $-0.92.

Based on 13 analysts, the average revenue estimation is $4.23M, with a low revenue estimation of $-700.00K, and a high estimation of $8.00M.

Editas Medicine Previous Earnings Dates & Reports

EDIT Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Editas Medicine's previous earnings date was Nov 8, 2021 for its fiscal quarter ended Sep 30, 2021.

EDIT's earnings per share (EPS) was $-0.57, beating the consensus analysts forecast of $-0.82 by 30.49%.

The EPS was higher than the previous fiscal quarter (Jun 2021) by -29.63%, and lower than the same period a year before (Sep 2020) by -575.00%.

EDIT Previous Earnings Date & Report Recap: Dec 2020 (FY)

Editas Medicine's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.

EDIT's earnings per share (EPS) was $-2.00, missing the consensus analysts forecast of $-1.73 by 15.61% , and higher than the previous year's EPS (Dec 2019) by -25.65%.

Revenues were $90.73M, better than the forecast of $84.48M by 7.40%, and up by 341.93% from previous year's revenue.

The company reported a net income of $-115.98M.

Editas Medicine reported a free cash flow of $-187.00M for its fiscal year, compared to $-46.84M a year ago.

The company ended the fiscal year with $26.14M in total debt, a decrease of -10.13% compared to the previous year.